Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021026

« Back to Dashboard

NDA 021026 describes VUSION, which is a drug marketed by Mylan Pharms Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the VUSION profile page.

The generic ingredient in VUSION is miconazole nitrate; petrolatum, white; zinc oxide. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole nitrate; petrolatum, white; zinc oxide profile page.

Summary for 021026

Tradename:	VUSION
Applicant:	Mylan Pharms Inc
Ingredient:	miconazole nitrate; petrolatum, white; zinc oxide
Patents:	1
Formulation / Manufacturing:	see details

Pharmacology for NDA: 021026

Ingredient-type	Azoles

Suppliers and Packaging for NDA: 021026

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
VUSION	miconazole nitrate; petrolatum, white; zinc oxide	OINTMENT;TOPICAL	021026	NDA	Prestium Pharma, Inc.	40076-002	N	40076-002-50

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	OINTMENT;TOPICAL			Strength	0.25%;81.35%;15%
Approval Date:	Feb 16, 2006	TE:		RLD:	Yes
Patent:	➤ Sign Up	Patent Expiration:	Mar 30, 2028	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	USE FOR TREATMENT OF DIAPER DERMATITIS COMPLICATED BY CANDIDIASIS

Expired US Patents for NDA 021026

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Pharms Inc	VUSION	miconazole nitrate; petrolatum, white; zinc oxide	OINTMENT;TOPICAL	021026-001	Feb 16, 2006	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.